DE3872198D1 - Aus l681,512 isolierte antientzuendbare und anti-degenerative vebindungen. - Google Patents

Aus l681,512 isolierte antientzuendbare und anti-degenerative vebindungen.

Info

Publication number
DE3872198D1
DE3872198D1 DE8888202882T DE3872198T DE3872198D1 DE 3872198 D1 DE3872198 D1 DE 3872198D1 DE 8888202882 T DE8888202882 T DE 8888202882T DE 3872198 T DE3872198 T DE 3872198T DE 3872198 D1 DE3872198 D1 DE 3872198D1
Authority
DE
Germany
Prior art keywords
degenerative
liable
insulated
connections
connections insulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888202882T
Other languages
English (en)
Other versions
DE3872198T2 (de
Inventor
Richard W Burg
Eugene L Dulaney
Otto D Hensens
Jerrold M Liesch
John G Ondeyka
Carol F Wichmann
Leeyuan Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3872198D1 publication Critical patent/DE3872198D1/de
Publication of DE3872198T2 publication Critical patent/DE3872198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE8888202882T 1987-12-21 1988-12-14 Aus l681,512 isolierte antientzuendbare und anti-degenerative vebindungen. Expired - Fee Related DE3872198T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/135,949 US4871727A (en) 1987-12-21 1987-12-21 Anti-inflammatory and antidegenerative compounds isolated from L-681,512

Publications (2)

Publication Number Publication Date
DE3872198D1 true DE3872198D1 (de) 1992-07-23
DE3872198T2 DE3872198T2 (de) 1992-12-03

Family

ID=22470522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888202882T Expired - Fee Related DE3872198T2 (de) 1987-12-21 1988-12-14 Aus l681,512 isolierte antientzuendbare und anti-degenerative vebindungen.

Country Status (4)

Country Link
US (1) US4871727A (de)
EP (1) EP0322036B1 (de)
JP (1) JPH01221391A (de)
DE (1) DE3872198T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703067A (en) * 1995-05-08 1997-12-30 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1997028180A1 (en) * 1996-01-31 1997-08-07 Merck & Co., Inc. Antifungal agent
IL130249A0 (en) 1996-12-20 2000-06-01 Novo Nordisk As Meiosis regulating compounds
US5789438A (en) * 1997-09-05 1998-08-04 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
JP2005511767A (ja) * 2001-12-14 2005-04-28 セダーズ−シナイ メディカル センター Ｈｉｖ−１プロテアーゼインヒビターおよびその誘導体の、炎症の処置における使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271390A (en) * 1963-09-13 1966-09-06 Squibb & Sons Inc Sulfurenic acid and derivatives thereof
US3625194A (en) * 1969-05-12 1971-12-07 Serdex Soc D Etudes De Rech De Triterpenic alcohols, process for their preparation and therapeutical compositions containing same
JPS5811960B2 (ja) * 1978-08-25 1983-03-05 株式会社岡安商店 シクロブラノ−ルこはく酸エステルアルカリ金属塩
JPS5811959B2 (ja) * 1978-08-25 1983-03-05 株式会社岡安商店 シクロアルテノ−ルこはく酸エステルアルカリ金属塩

Also Published As

Publication number Publication date
JPH01221391A (ja) 1989-09-04
US4871727A (en) 1989-10-03
DE3872198T2 (de) 1992-12-03
EP0322036B1 (de) 1992-06-17
EP0322036A1 (de) 1989-06-28

Similar Documents

Publication Publication Date Title
NO884333L (no) 1,4-dihydropyridiner.
DE3872198D1 (de) Aus l681,512 isolierte antientzuendbare und anti-degenerative vebindungen.
IT8521944A0 (it) 1,4-diidropiridine-2-sostituite.
FI880552A (fi) Substituerade 2,6-substituerade pyridinfoereningar.
FI881829A (fi) 1,3-dioxaner.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
FI881899A (fi) Nya 2 ,16 -diaminoandrostaner.
FI855182A (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI850994A0 (fi) Foerfarande foer framstaellning av nya 1,2,4-triazacykloalkadienderivat.
FI861950A0 (fi) 1,3-dioxan-etrar.
FI863300A0 (fi) 7-oxo-4-tia-1-azabicyclo/3,2,0/ hept-2-enderivat.
FI865244A0 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
FI880417A0 (fi) Foerfarande foer framstaellning av 14,15-substituerade lanosteroler.
ES2015605B3 (es) 3,4-dihidro-2h-piranos.
DE3876651D1 (de) 3-amino-2,4,5-trifluorobenzoesaeure und ihre herstellung.
FI865158A (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
FI884599A (fi) Foerfarande foer framstaellning av 3,3-disubstituerade indoliner.
FI880081A0 (fi) 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat.
FI850995A0 (fi) Foerfarande foer framstaellning av nya 3-merkapto-1,2,4-triazacykloalkadienderivat.
FI880658A (fi) Oximetrar av 2,6-dioxabicyklo-/3,3,0/ oktanoner.
IT8620495A0 (it) 2,4-dicloro-5-nitro-tiazolo.
FI880408A (fi) Foerfarande foer framstaellning av 1,4-naftokinon.
FI883115A (fi) Foerfarande foer framstaellning av 1,5-bensotiazepinderivat.
FI900006A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5,6,7,8-tetrahydro-b-karbolinderivat.
ATE51400T1 (de) 3,4-dihydrobenzopyranderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee